Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical timolol maleate for small superficial infantile haemangioma in high-risk areas
ACTRN12619001685101Phase 3Completed
- Sponsor
- United Christian Hospital
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of timolol in Capillary Haemangioma (2 arms), sponsored by United Christian Hospital. Primary endpoints: Development of complications requiring additional intervention and Need for further treatment. Started Nov 2016; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ACTRN12619001685101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001685101.